Our Services
Medical Information
Helpful Resources
Published on: 2/25/2026
Memantine usually stabilizes or slows decline in moderate to severe Alzheimer’s rather than causing big improvements, so continued memory loss can reflect normal progression, a different diagnosis like MCI or another dementia, early treatment window, suboptimal dosing, or other medical issues that need attention.
Next steps include a medication and diagnosis review, testing for reversible causes, considering adding a cholinesterase inhibitor, and improving sleep, exercise, and vascular health, with urgent care for sudden changes; there are several factors to consider, and the critical details that could change your plan are outlined below.
If you or someone you love is taking memantine and memory still seems to be getting worse, it can feel discouraging. Many people expect noticeable improvement. When that doesn't happen, it's natural to wonder: Is the medication failing? Is something else going on?
Let's look at what memantine is designed to do, why it may not seem to work, and what medically appropriate next steps you can take.
Memantine is a prescription medication approved to treat moderate to severe Alzheimer's disease. It works by regulating glutamate, a brain chemical involved in learning and memory.
In Alzheimer's disease, too much glutamate activity can overstimulate brain cells and contribute to damage. Memantine helps by:
However, it's important to understand one key point:
Memantine does not cure Alzheimer's disease.
It may slow symptoms or help stabilize them for a period of time.
For many patients, the goal of memantine is slower decline, not full improvement.
There are several medically recognized reasons why memory may continue to fade even while taking memantine.
Alzheimer's disease and other dementias are progressive brain disorders. Even with appropriate treatment, symptoms can worsen over time.
Memantine may:
But it typically does not stop progression completely.
If memory continues to worsen gradually, this may reflect the natural course of the disease—not necessarily treatment failure.
Not all memory problems are caused by Alzheimer's disease.
Other conditions that can cause memory decline include:
Memantine is specifically approved for moderate to severe Alzheimer's disease. If you're experiencing memory changes that don't quite fit Alzheimer's patterns, you may want to check if your symptoms align more closely with Mild Cognitive Impairment using a free symptom assessment tool before your next doctor's appointment.
If symptoms don't fit the expected pattern, a reevaluation by a doctor is appropriate.
Memantine does not work immediately.
It may take:
before stabilization is noticeable.
If memantine was started recently, your doctor may recommend continuing it a bit longer before evaluating effectiveness.
Memantine is usually started at a low dose and gradually increased to reduce side effects.
If the dose is:
It may not provide the expected benefit.
Never adjust the dose on your own. Speak to your doctor about whether the current dose is appropriate.
Memantine is often used alone in moderate to severe Alzheimer's disease, but sometimes it is combined with a cholinesterase inhibitor such as:
Combination therapy may offer additional benefit in some patients.
If memantine alone isn't providing expected results, your doctor may consider adjusting the treatment plan.
Memory decline isn't always caused by worsening dementia. It can be affected by:
Sudden or rapid worsening of memory is not typical of gradual Alzheimer's progression and should be evaluated promptly.
While slow cognitive decline can be part of dementia, some symptoms require immediate medical evaluation:
These may signal stroke, infection, or another serious medical issue.
If these occur, seek urgent medical care.
If memantine doesn't seem to be working, here's what doctors commonly recommend:
Ask your doctor:
Bring a full list of all prescriptions and supplements.
Doctors may recommend:
Accurate diagnosis is critical for proper treatment.
Treatable contributors to cognitive decline include:
Correcting these may significantly improve symptoms.
While medications like memantine can help, lifestyle factors play a powerful role in brain health.
Evidence-based recommendations include:
These steps won't cure dementia but can help slow decline and improve quality of life.
If symptoms are complex or progressing faster than expected, your doctor may refer you to:
Specialists can offer more detailed evaluation and updated treatment options.
In some cases, after careful evaluation, a doctor may decide that memantine is not providing meaningful benefit.
When this happens, the care plan may shift to focus on:
Stopping memantine should only be done under medical supervision.
It's important to be honest: memantine is not a cure, and it does not work the same way for everyone.
However:
The most important step is open communication with your healthcare provider.
You should speak to a doctor if:
Memory problems can sometimes signal serious medical conditions. If anything feels severe, sudden, or life-threatening, seek immediate medical care.
If memantine doesn't seem to be working, don't panic—but don't ignore it either.
The next best step is thoughtful medical review. In many cases:
Before your next medical appointment, you might find it helpful to use a free AI-powered assessment to evaluate if your symptoms could be related to Mild Cognitive Impairment rather than Alzheimer's—this information can guide more productive conversations with your healthcare provider.
Most importantly, remember that you are not alone in this process. Cognitive changes are common, and early, proactive medical care offers the best path forward.
If you have concerns about memory loss or believe something serious may be happening, speak to a doctor promptly.
(References)
* Kaden, D., & Pröbstel, A. K. (2022). Update on Pharmacological Treatment of Alzheimer's Disease. Fortschritte der Neurologie Psychiatrie, 90(05), 241-253.
* Caramelli, P., & Bahia, V. S. (2018). Reversible dementia: a challenging but rewarding diagnosis. Dementia & Neuropsychologia, 12(3), 241-247.
* Petersen, R. C., & Lopez, O. L. (2022). Clinical Practice Guidelines for Dementia: A Review of the Current State. Journal of Alzheimer's Disease, 89(1), 1-12.
* Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., ... & Mukadam, N. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet, 396(10248), 413-446.
* Cummings, J., Feldman, H. H., & Scheltens, P. (2023). The New Era of Disease-Modifying Therapeutics for Alzheimer's Disease. Drugs, 83(1), 1-12.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.